VYEPTI 100mg 100mg/ml concentrate for solution for infusion LUNDBECK ORIGINAL MEDICINE
Chemical substance: eptinezumab
Active substance
Results for the substance eptinezumab
1 result
About this active substance
Eptinezumab is a medication used for the prevention of migraine in adults. It works by blocking the CGRP protein, which is involved in triggering and maintaining migraine attacks.
Eptinezumab is administered by intravenous infusion, usually once every three months, according to the neurologist's instructions. The dose may be adjusted depending on the patient's response to treatment.
Side effects may include infusion site reactions, nasal congestion, fatigue, or, rarely, severe allergic reactions. Medical monitoring is recommended throughout the treatment.
Eptinezumab is a modern and effective option for migraine prevention, helping to reduce the frequency and severity of attacks and improve patients' quality of life.
Eptinezumab is administered by intravenous infusion, usually once every three months, according to the neurologist's instructions. The dose may be adjusted depending on the patient's response to treatment.
Side effects may include infusion site reactions, nasal congestion, fatigue, or, rarely, severe allergic reactions. Medical monitoring is recommended throughout the treatment.
Eptinezumab is a modern and effective option for migraine prevention, helping to reduce the frequency and severity of attacks and improve patients' quality of life.